Diffuse parenchymal lung disease: a different perspective

K.M. Antoniou, A.U. Wells

Source: Breathe 2008; 4: 240-241
Journal Issue: March

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K.M. Antoniou, A.U. Wells. Diffuse parenchymal lung disease: a different perspective. Breathe 2008; 4: 240-241

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diffuse parenchymal lung disease
Source: International Congress 2016 – Clinical year in review
Year: 2016


Diffuse parenchymal lung disease
Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017
Year: 2017



Diffuse parenchymal drug related lung disease: report of a series
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Diffuse parenchymal lung diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Diffuse parenchymal lung diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Diffuse parenchymal lung diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Diffuse parenchymal lung diseases
Source: ERS Skills Course 2016
Year: 2016

Update on diffuse parenchymal lung disease
Source: Eur Respir Rev 2009; 19: 97-108
Year: 2010


Alveoscopy in diffuse interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 244s
Year: 2007

Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management?
Source: Breathe 2008; 4: 233-239
Year: 2008


The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group
Source: Eur Respir J 2005; 26: Suppl. 49, 500s
Year: 2005

Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014


A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Psychological impact of diffuse infiltrative lung disease
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018


A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Clinical course and outcome of vasculitis related interstitial lung disease
Source: International Congress 2014 – ILDs 2
Year: 2014

Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



Proportion of idiopathic pulmonary fibrosis among interstitial lung disease in a tertiary care center and its response to treatment
Source: International Congress 2014 – ILDs 5
Year: 2014